Skip to main content
Li Zeng, MD, Pathology, San Leandro, CA

LiLisaZengMD

Pathology San Leandro, CA

Anatomic Pathology, Clinical Pathology

Assistant Professor, Anatomy & Cellular Biology, Tufts University School of Medicine

Are you Dr. Zeng?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 16 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    2500 Merced St
    San Leandro, CA 94577
    Phone+1 510-454-1000

Summary

  • Dr. Li Zeng, MD is a board certified pathologist in San Leandro, California. She is currently licensed to practice medicine in California. She is affiliated with Kaiser Permanente San Leandro Medical Center and San Leandro Hospital.

Education & Training

  • University of California Davis Health
    University of California Davis HealthResidency, Pathology-Anatomic and Clinical, 1998 - 2002
  • West China University of Medical Sciences
    West China University of Medical SciencesClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2026
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

Press Mentions

  • Remedium Bio Announces Successful $2.3M Expanded Seed Raise
    Remedium Bio Announces Successful $2.3M Expanded Seed RaiseAugust 15th, 2022
  • CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease
    CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s DiseaseDecember 10th, 2018